Alice Ho Miu Ling Nethersole Hospital is an acute district general hospital managed under the New Territories East Cluster of the Hospital Authority in Hong Kong.

There are 605 beds in Alice Ho Miu Ling Nethersole Hospital.

During the past decade, Alice Ho Miu Ling Nethersole Hospital conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 9 clinical trials were completed, i.e. on average, 56.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 6 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Alice Ho Miu Ling Nethersole Hospital" #1 sponsor was "Chinese University of Hong Kong" with 11 trials, followed by "Gilead Sciences" with 8 trials sponsored, "Hospital Authority, Hong Kong" with 3 trials sponsored, "Alice Ho Miu Ling Nethersole Hospital" with 2 trials sponsored and "Boehringer Ingelheim" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Alice Ho Miu Ling Nethersole Hospital" #1 collaborator was "Chinese University of Hong Kong" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "F-star Therapeutics, Inc." with 1 trials as a collaborator and "Vir Biotechnology, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Alice Ho Miu Ling Nethersole Hospital" are "Chronic Hepatitis B" (4 trials), "Cataract" (2 trials), "HBV" (2 trials), "Hepatitis B" (2 trials) and "Nonalcoholic Steatohepatitis" (2 trials). Many other conditions were trialed in "Alice Ho Miu Ling Nethersole Hospital" in a lesser frequency.

Most popular intervention types in "Alice Ho Miu Ling Nethersole Hospital" are "Drug" (17 trials), "Other" (4 trials), "Procedure" (3 trials), "Diagnostic Test" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "TAF" (4 trials), "TDF" (3 trials), "Clevudine" (2 trials) and "Placebo to match SEL 18 mg" (2 trials). Other intervention names were less common.

The vast majority of trials in "Alice Ho Miu Ling Nethersole Hospital" are 29 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Alice Ho Miu Ling Nethersole Hospital". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Alice Ho Miu Ling Nethersole Hospital, 1 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Alice Ho Miu Ling Nethersole Hospital, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 9 trials that are defined as “Not Applicable".